Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Romosozumab bulk supplier for pharma manufacturers

Romosozumab 105 mg/1.17 mL Suppliers & Bulk Manufacturers

Available Forms: injection (prefilled syringe)

Available Strengths: 105 mg/1.17 mL

Reference Brands: Evenity (USA/EU)

Category: Osteoporosis

Romosozumab is a monoclonal antibody used for the treatment of osteoporosis in postmenopausal women and men at high risk of fracture. It works by inhibiting the protein sclerostin, which increases bone formation and decreases bone resorption. Romosozumab is administered as a monthly subcutaneous injection and helps improve bone density and reduce fracture risk.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Romosozumab — third party manufacturing & bulk supply

Romosozumab 105 mg/1.17 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Romosozumab listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Romosozumab →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Romosozumab is used to treat osteoporosis in postmenopausal women and men at high risk of fracture.

Romosozumab is made from a humanized monoclonal antibody that binds to and inhibits sclerostin, a protein that limits bone formation.

The trade name of Romosozumab is Evenity.

Romosozumab is made by Amgen Inc. and UCB Pharma.

The generic name of the product is Romosozumab.

The brand name of Romosozumab is Evenity.

Romosozumab is manufactured by Amgen Inc. in the United States and also by UCB Pharma in Belgium.

Related Products

Strontium Ranelate

Strength:
2 g

Form: Sachet

Reference Brands: Osseor (EU/UK)

View Details
Abaloparatide

Strength:
80 mcg

Form: injection (prefilled syringe)

Reference Brands: Tymlos (USA), Eladynos (EU)

View Details
Pamidronate Disodium

Strength:
15 mg, 30 mg, 60 mg, 90 mg

Form: Injection

Reference Brands: Aredia (USA/EU)

View Details
Calcitonin Salmon

Strength:
100 IU/mL, 200 IU/mL

Form: Injection / nasal spray

Reference Brands: Fortical (USA), Miacalcin (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.